Detailed deletion mapping of chromosome band 14q32 in human neuroblastoma defines a 1.1-Mb region of common allelic loss

被引:31
作者
Hoshi, M
Otagiri, N
Shiwaku, HO
Asakawa, S
Shimizu, N
Kaneko, Y
Ohi, R
Hayashi, Y
Horii, A
机构
[1] Tohoku Univ, Sch Med, Dept Mol Pathol, Aoba Ku, Sendai, Miyagi 9808575, Japan
[2] Tohoku Univ, Sch Med, Dept Pediat Surg, Aoba Ku, Sendai, Miyagi 9808575, Japan
[3] Tohoku Univ, Sch Med, Dept Pediat Hematol & Oncol, Aoba Ku, Sendai, Miyagi 9808575, Japan
[4] Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, Tokyo 1608792, Japan
[5] Saitama Canc Ctr, Dept Canc Chemotherapy, Ina, Saitama 3620806, Japan
关键词
D O I
10.1054/bjoc.2000.1108
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neuroblastoma (NB) is a well-known malignant disease in infants, but its molecular mechanisms have not yet been fully elucidated. To investigate the genetic contribution of abnormalities on the long arm of chromosome 14 (14q) in NE, we analysed loss of heterozygosity (LOH) in 54 primary NE samples using 12 microsatellite markers on 14q32. Seventeen (31%) of 54 tumours showed LOH at one or more of the markers analysed, and the smallest common region of allelic loss was identified between D14S62 and D14S987. This region was estimated to be 1-cM long from the linkage map. Fluorescence in situ hybridization also confirmed the loss. There was no statistical correlation between LOH and any clinicopathologic features, including age, stage, amplification of MYCN and ploidy. We further constructed a contig spanning the lost region using bacterial artificial chromosome and estimated this region to be approximately 1.1-Mb by pulsed-field gel electrophoresis. Our results will contribute to cloning and characterizing the putative tumour-associated gene(s) in 14q32 in NB. (C) 2000 Cancer Research Campaign.
引用
收藏
页码:1801 / 1807
页数:7
相关论文
共 43 条
[1]   HIGH-RESOLUTION CYTOGENETIC MAPPING OF THE SHORT ARM OF CHROMOSOME-1 WITH NEWLY ISOLATED 411-COSMID MARKERS BY FLUORESCENCE IN-SITU HYBRIDIZATION - THE PRECISE ORDER OF 18 MARKERS ON 1P36.1 ON PROPHASE CHROMOSOMES AND STRETCHED DNAS [J].
ARIYAMA, T ;
INAZAWA, J ;
EZAKI, T ;
NAKAMURA, Y ;
HORII, A ;
ABE, T .
GENOMICS, 1995, 25 (01) :114-123
[2]   Human BAC library: Construction and rapid screening [J].
Asakawa, S ;
Abe, I ;
Kudoh, Y ;
Kishi, N ;
Wang, YM ;
Kubota, R ;
Kudoh, J ;
Kawasaki, K ;
Minoshima, S ;
Shimizu, N .
GENE, 1997, 191 (01) :69-79
[3]  
Bandera CA, 1997, CANCER RES, V57, P513
[4]   Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma [J].
Bown, N ;
Cotterill, S ;
Lastowska, M ;
O'Neill, S ;
Pearson, ADJ ;
Plantaz, D ;
Meddeb, M ;
Danglot, G ;
Brinkschmidt, C ;
Christiansen, H ;
Laureys, G ;
Speleman, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (25) :1954-1961
[5]  
BRODEUR GM, 1981, CANCER RES, V41, P4678
[6]  
BRODEUR GM, 1992, CANCER-AM CANCER SOC, V70, P1685, DOI 10.1002/1097-0142(19920915)70:4+<1685::AID-CNCR2820701607>3.0.CO
[7]  
2-H
[8]   EVIDENCE FOR 2 TUMOR-SUPPRESSOR LOCI ON CHROMOSOMAL BANDS-1P35-36 INVOLVED IN NEUROBLASTOMA - ONE PROBABLY IMPRINTED, ANOTHER ASSOCIATED WITH N-MYC AMPLIFICATION [J].
CARON, H ;
PETER, M ;
VANSLUIS, P ;
SPELEMAN, F ;
DEKRAKER, J ;
LAUREYS, G ;
MICHON, J ;
BRUGIERES, L ;
VOUTE, PA ;
WESTERVELD, A ;
SLATER, R ;
DELATTRE, O ;
VERSTEEG, R .
HUMAN MOLECULAR GENETICS, 1995, 4 (04) :535-539
[9]   Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma [J].
Caron, H ;
vanSluis, P ;
deKraker, J ;
Bokkerink, J ;
Egeler, M ;
Laureys, G ;
Slater, R ;
Westerveld, A ;
Voute, PA ;
Versteeg, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (04) :225-230
[10]   ALLELIC LOSS OF CHROMOSOME-1P36 IN NEUROBLASTOMA IS OF PREFERENTIAL MATERNAL ORIGIN AND CORRELATES WITH N-MYC AMPLIFICATION [J].
CARON, H ;
VANSLUIS, P ;
VANHOEVE, M ;
DEKRAKER, J ;
BRAS, J ;
SLATER, R ;
MANNENS, M ;
VOUTE, PA ;
WESTERVELD, A ;
VERSTEEG, R .
NATURE GENETICS, 1993, 4 (02) :187-190